EU Horizon funding · Belgium · NACE 86
Horizon Europe funding for healthcare companies in Belgium
NACE 86 · Human health activities
6 healthcare companies in Belgium received €2.9M in EU research and innovation funding across 10 Horizon Europe and Horizon 2020 projects starting between 2015 and 2025; 78% of the money went to SMEs.
- EU contribution
- €2.9M
- 2015–2025 project starts
- Funded companies
- 6
- 5 of them SMEs
- Projects
- 10
- Horizon Europe and Horizon 2020
- Share to SMEs
- 78%
- €2.3M to SMEs
Industry is known only for companies in Belgium that we matched to the national business register; funded companies we could not match are counted on the Belgium country page but not here.
In numbers
Healthcare companies in Belgium rank 36th of 40 industry divisions in Belgium by total EU funding received.
Of the total, Horizon 2020 (2014–2020) accounts for €2.4M across 8 projects and Horizon Europe (2021–2027) for €553k across 2 projects.
The strongest start year was 2015, when projects worth €569k to these companies began.
The largest funding route was the Research and Innovation Action (RIA) with €1.8M (61% of the total, 5 projects).
Coris Bioconcept (Gembloux) is the largest recipient with €1.4M over 4 projects.
The average funded company received €484k; 83% of the companies are SMEs.
By programme
Horizon 2020 2014–2020
€2.4M
8 projects · 81% of the total
Horizon Europe 2021–2027
€553k
2 projects · 19% of the total
Funding by start year
EU contribution to these companies, by the year their project started.
| Year | EU contribution |
|---|---|
| 2015 |
€569k
|
| 2016 |
€132k
|
| 2017 |
€542k
|
| 2018 |
€479k
|
| 2019 |
€373k
|
| 2021 |
€256k
|
| 2022 |
€376k
|
| 2025 |
€178k
|
2014–2020 starts (mostly Horizon 2020) 2021 onwards (Horizon Europe)
Largest recipients
Companies with the highest EU contribution, Horizon Europe and Horizon 2020 combined.
| # | Company | Programmes | Projects | EU contribution |
|---|---|---|---|---|
| 1 | Coris Bioconcept SME Gembloux | Horizon 2020 | 4 | €1.4M |
| 2 | Eurofins Amatsigroup Gent | Horizon 2020 | 2 | €629k |
| 3 | InnoSer België SME Diepenbeek | Horizon Europe | 1 | €376k |
| 4 | International Drug Development Institute SME Ottignies-Louvain-la-Neuve | Horizon Europe | 1 | €178k |
| 5 | Apitope International SME Diepenbeek | Horizon 2020 | 1 | €169k |
| 6 | Biocartis SME Mechelen | Horizon 2020 | 1 | €132k |
Funding schemes
How the money reached these companies.
-
Research and Innovation Action (RIA) €1.8M5 projects HORIZON-RIA · RIA 61%
-
Marie Skłodowska-Curie Actions €639k3 projects MSCA-ITN · MSCA-ITN-ETN 22%
-
Innovative Medicines Initiative 2 €318k1 project IMI2-RIA 11%
-
Joint Undertaking actions (Horizon Europe) €178k1 project HORIZON-JU-RIA 6%
Notable recent projects
Recent projects with the largest EU contribution to these companies. Links open the project on CORDIS.
-
RealiseD
Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
Started 2025 Horizon Europe Joint Undertaking actions (Horizon Europe) Total EU contribution €8.5M to these companies €178k
-
INNPAPER
Innovative and Smart Printed Electronics based on Multifunctionalized Paper: from Smart Labelling to Point of Care Bioplatforms
Started 2018 Horizon 2020 Research and Innovation Action (RIA) Total EU contribution €7.4M to these companies €479k
-
HEAL
HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart
Started 2022 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €5.8M to these companies €376k
-
NEW DEAL
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases
Started 2017 Horizon 2020 Research and Innovation Action (RIA) Total EU contribution €6M to these companies €373k
-
VHFMoDRAD
Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics
Started 2019 Horizon 2020 Research and Innovation Action (RIA) Total EU contribution €3.3M to these companies €373k
Other funded industries in Belgium
| Industry (NACE) | Companies | Projects | To SMEs | EU contribution |
|---|---|---|---|---|
| 71 Architecture & Engineering | 112 | 429 | 51% |
€200M
|
| 62 Software & IT Services | 153 | 384 | 71% |
€164M
|
| 72 Research & Development | 93 | 311 | 78% |
€159M
|
| 70 Management Consulting | 128 | 448 | 80% |
€130M
|
| 82 Business Support Services | 31 | 189 | 79% |
€62M
|
| 74 Other Professional & Technical Services | 30 | 87 | 93% |
€47M
|
| 20 Chemicals Manufacturing | 37 | 107 | 17% |
€47M
|
| 46 Wholesale | 58 | 140 | 26% |
€46M
|
| 26 Electronics Manufacturing | 41 | 101 | 48% |
€46M
|
| 27 Electrical Equipment Manufacturing | 19 | 70 | 79% |
€44M
|
Healthcare in other countries
| Country | Companies | Projects | To SMEs | EU contribution |
|---|---|---|---|---|
| Sweden | 5 | 6 | 77% |
€5.5M
|
Get company lists in Claude
Ask Claude for companies by industry, size and region, straight from official European business registers, and export the list as CSV.
Source and method
Source: CORDIS – © European Union, 1994–2026, CC BY 4.0. Data modified: aggregated by EU Company Leads. Project and participant data from CORDIS (Horizon Europe and Horizon 2020 project datasets), licensed under CC BY 4.0.
We count organisations that CORDIS lists as private for-profit companies (activity type PRC) with an EU contribution above zero. Amounts are the EU contribution to those companies, not total project budgets; years are project start years. Industries use NACE Rev. 2.1 from the national business registers of France, Finland, Belgium, Estonia, Sweden and Czech Republic and are only known for companies matched to those registers. Figures computed Nov 17, 2026.